Market Tracker

03/30 4:30pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

9.60
Delayed Data
As of 4:00pm ET
 -0.63 / -6.16%
Today’s Change
4.00
Today|||52-Week Range
11.72
+11.11%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close10.23
Today’s open9.75
Day’s range9.03 - 10.31
Volume3,879,470
Average volume (3 months)1,297,366
Market cap$718.0M
Dividend yield--
Data as of 4:00pm ET, 03/30/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-505.33%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+700.24%
P/E ratio64.0
Price/Sales8.73
Price/Book6.85

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...-0.18-1.09%
TGTXTG Therapeutics Inc-0.25-2.14%
ADROAduro Biotech Inc-0.20-1.81%
HSKAHeska Corp+6.99+7.30%
Data as of 4:00pm ET, 03/30/2017

Financials

Next reporting dateMay 12, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$69.4M
Annual profit (last year)$10.8M
Net profit margin15.56%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark Robert Baker
Vice President-
Operations
Meryl J. Longval
Corporate headquarters
Tarrytown, New York

Forecasts